Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05116163 · ClinicalTrials.gov registry record · NA
Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology
A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 2
- Study locations
NCT05116163: Completed NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Brigham and Women's Hospital.
NCT05116163 is a NA study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 201 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05116163, a NA study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 2
- Study locations
Study Summary
The first aim of this study is to test the efficacy of a real-time provider-based individuation intervention to improve the receipt of high-quality rheumatic disease care among Black/African American and lower socioeconomic status (SES) individuals. The second aim is to determine the effect of the individuation intervention on provider-patient communication, adherence, provider trust and care satisfaction.
Primary Outcome
Documented receipt of high-quality care at the appointment or within 30 days of the appointment. The quality metrics for Lupus and RA include but are not limited to: Hydroxychloroquine (HCQ) initiation and Folic acid if receiving methotrexate, respectively. These items will be added together to form a score and the number of items completed out of the total will be the primary outcome measure compared across groups. The denominator is the patient-specific quality metrics they are eligible for an
Conditions Studied
Interventions
- BEHAVIORAL Individuation Intervention plus implicit bias educational modules
- OTHER Implicit bias educational modules
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2024-10-09 |
| Phase | NA |
What the finished NCT05116163 record still lists
NCT05116163 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Individuation Intervention plus implicit bias educational modules is the first listed.
NCT05116163 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05116163 about?
NCT05116163 is a clinical study titled "Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology". The first aim of this study is to test the efficacy of a real-time provider-based individuation intervention to improve the receipt of high-quality rheumatic disease care among Black/African American and lower socioeconomic status (SES) individuals. The second aim is to determine the effect of the i...
What is the current status of trial NCT05116163?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2022-06-17. Estimated completion is 2024-10-09.
What conditions does trial NCT05116163 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Systemic Lupus Erythematosus, Inflammatory Arthritis.
What interventions are being tested in trial NCT05116163?
The interventions under investigation include: Individuation Intervention plus implicit bias educational modules (BEHAVIORAL), Implicit bias educational modules (OTHER).
Who is sponsoring clinical trial NCT05116163?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05116163 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05116163's enrollment target sits among peer trials
201 83rd of 197 higher than 115 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI